000 01255 a2200313 4500
005 20250518063147.0
264 0 _c20191209
008 201912s 0 0 eng d
022 _a1878-3511
024 7 _a10.1016/j.ijid.2019.09.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Oers, Jos A H
245 0 0 _aWhy would procalcitonin perform better in patients with a SOFA-score less than 8?
_h[electronic resource]
260 _bInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
_c12 2019
300 _a185-186 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnti-Bacterial Agents
650 0 4 _aCritical Illness
650 0 4 _aHumans
650 0 4 _aOrgan Dysfunction Scores
650 0 4 _aPatients
650 0 4 _aProcalcitonin
700 1 _aNijsten, Maarten W
700 1 _ade Jong, Evelien
700 1 _aBeishuizen, Albertus
700 1 _ade Lange, Dylan W
773 0 _tInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
_gvol. 89
_gp. 185-186
856 4 0 _uhttps://doi.org/10.1016/j.ijid.2019.09.027
_zAvailable from publisher's website
999 _c30174904
_d30174904